Clinical Application of Liquid Biopsy in Targeted Therapy of Metastatic Colorectal Cancer
Background. Colorectal cancers (CRC) shed DNA into blood circulation. There is growing evidence that the analysis of circulating tumor DNA can be effectively used for monitoring of disease, to track tumor heterogeneity and to evaluate response to treatment. Case Presentation. Here, we describe two c...
Saved in:
| Main Authors: | Jörg Trojan, Susanne Klein-Scory, Christine Koch, Wolff Schmiegel, Alexander Baraniskin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Case Reports in Oncological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2017/6139634 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mutational profiling using liquid biopsy to guide targeted therapy in patients with metastatic cancer
by: Omayma Mazouji, et al.
Published: (2025-04-01) -
Evaluation of Bridge Capture technology for mutation profiling in liquid biopsies of metastatic colorectal cancer patients
by: Aparna Ganesan, et al.
Published: (2025-07-01) -
Liquid Biopsy for Colorectal Cancer: Advancing Detection and Clinical Application
by: Yan Li, et al.
Published: (2025-03-01) -
Targeted liquid biopsy for brain tumors
by: Muhammad Izhar, et al.
Published: (2024-12-01) -
The importance of circulating tumor products as „liquid biopsies” in colorectal cancer
by: Alina Miscoci, et al.
Published: (2018-04-01)